The effect of non-steroidal anti-inflammatory eye drops vs placebo on macular vessel density following phacoemulsification

Comparison of the effect of ketorolac eye drops versus placebo on macular vessel density in cataract patients who underwent phacoemulsification

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220216054042N1

Enrollment

Registered

2023-05-08

Start date

2023-05-05

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Phacoemulsification. Age-related cataract

Interventions

Intervention 1: Intervention group: The intervention group patients will receive topical ketorolac drops (prescribed for its anti-inflammatory effects, not for pain relief) administered to the eye fou

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Cataract patients who underwent phacoemulsification

Exclusion criteria

Exclusion criteria: Not consenting to participate in the study Age of fewer than 18 years History of eye disease affecting the optic nerve and macula History of intraocular surgery History of neurological diseases History of systemic diseases with ocular manifestations

Design outcomes

Primary

Measure	Time frame
Size of foveal avascular zone. Timepoint: 21 days after initiating the intervention. Method of measurement: Optical coherence tomography.;Parafoveal vessel density. Timepoint: 21 days after initiating the intervention. Method of measurement: Optical coherence tomography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Dehghani

Esfahan University of Medical Sciences

dehghani@med.mui.ac.ir+98 31 3792 3876

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026